The free selection of patient size estimation methods results in inconsistent CT size-adjusted dose values, compromising the goals of the CMS measure and underscoring the need for specified calculation methods and protocol-specific thresholds.
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Assessing internal carotid artery stenosis: Diagnostic Value of photon-counting detector CT angiography compared to Doppler ultrasound
Ischemic stroke constitutes a leading cause of morbidity and mortality, particularly in aging populations in which the prevalence of cardiovascular risk factors is rising [1,2]. Here, atherosclerotic stenosis of the internal carotid artery (ICA) is a major risk factor to ischemic stroke. Determining the need for carotid endarterectomy is crucial as the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the European Carotid Surgery Trial provide evidence for the significant redu…
-
New Mammography Research Examines Impact of High-Resolution DBT
In a recent interview, Jamie Williams, M.D., discussed newly published research findings revealing the impact of high-resolution digital breast tomosynthesis (DBT) on breast cancer detection and recall rates.
-
Data transparency is lacking for FDA-cleared Alzheimer's AI technology
Lack of transparency raises concerns about algorithmic bias impacting care planning for patients with Alzheimer’s disease.
-
Fujifilm Introduces Portable Digital Radiography System
tim.hodson
Wed, 07/30/2025 – 12:07
July 30, 2025 — Fujifilm Healthcare Americas Corp., a leading provider of diagnostic and enterprise imaging solutions, has announced the U.S. launch of the FDR Go iQ, a portable digital radiography (DR) solution built for hospitals and ambulatory surgery centers. Equipped with intuitive touchscreen controls and a display at the tube head, as well as convenient built-in smart charging, technologists can acquire x-ray room image quality at the patie…
-
AI-Based Breast Cancer Risk Software Gets FDA Breakthrough Device Designation
tim.hodson
Wed, 07/30/2025 – 10:27
July 29, 2025 — A new technology that harnesses AI to analyze mammograms and improve the accuracy of predicting a woman’s personalized five-year risk of developing breast cancer has received Breakthrough Device designation from the Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, the software has been licensed to Prognosia Inc., a WashU startup company.
The system analyzes mammo… -
Updated MRI-Based AI Software Offers Automated Segmentation and Volumetric Reporting of Brain Metastases and Meningiomas
The addition of two new AI-enabled models for the latest version of the NeuroQuant Brain Tumor software facilitates automated tracking of the progression of brain tumors and meningiomas.
-
Targeted but Toxic? Addressing the Safety Challenges of ADCs
Antibody-drug conjugates offer targeted power but come with distinct side effects. Learn how clinicians are tackling toxicity while maximizing efficacy in metastatic breast cancer. Medscape Oncology
-
CAC of Zero? Try to Keep It That Way
When patients with a coronary artery calcium score of 0 were followed long term in an observational study, scores stayed at 0 longer in those with the fewest cardiovascular risk factors. Medscape Medical News
-
Top Five Radiology Content — July 2025
Catch up on the most-well viewed radiology content in July 2025.